Dr Stefan Rauh

Dr Stefan Rauh

Dr Stefan Rauh

Interniste / Oncologue médical

Spécialités Cliniques

Interniste/ oncologue médical  
Actuellement chef de pôle /service ontologique et soins palliatifs (depuis le 01.11.2021)

Langues parlées

Luxembourgeois, Allemand, Français, (Italien)

Agréé au CHEM depuis

1999

Formation professionnelle

Faculté de Médicine de Munich RFA et Lausanne, Suisse, (stages en Philadelphie et San Francisco USA)
Formation de spécialisation en Médicine and Oncologie à la TU Munich, CHRU Nancy (France) et au CHL Luxembourg. 
Dissertation en radiologie TU Munich
Diplôme de spécialisation en Médicine Interne 2018 (Trier, FRG)
DU sénologie (CHU Nancy) 2002
ESMO exam 2004

Parcours professionnel post-études

1999: création d’un service d’oncologie avec hôpital de jour ambulatoire et service palliatif intégré a Differdange  (HPMA) 
Depuis 2010 : (fusion of HPMA and CHEM Esch) : activités dans le service d’oncologie et des soins palliatifs Esch

Autres activités Luxembourg : 

Membre fondateur de la Société Luxembourgeoise d’Oncologie (SLO) ; président de la SLO depuis 2020
Consultant du Plan Cancer 2
Maitre de Stage du cycle de spécialisation en oncologie de l’Université du Luxembourg (2021) et de la Médecine Générale (2010).
Représentant national du Luxembourg en oncologie médicale de l’Union Européenne des Médecins Spécialistes (UEMS) ; membre de l’ UEMS  working group  pour le développement du « European Training Requirement  (ETR) catalogue » en Oncologie Médicale
Représentant national de la European Society of Hematology

Memberships
European Society of Medical Oncology  

membre depuis 1998
core member, ESMO Public Policy Committee 
National Representative   2006 - 2014  et depuis 2020 
Chair, ESMO  Practising Oncologists’ Committee  2015 -2020
Chair, ESMO Quality Task Force 2015-2017
Membre, ESMO Educational Steering Committee 2017- 20
Membre ESMO Executive Board 2015 et 2016
Assistant Editor of ESMO Open Cancer Horizons 2015-2017
Orateur des congres annuels 2014-2020
Directeur scientifique des 1er et 2ieme ESMO Practicing Oncologists’ Update conférences  (2017 Lisbon, 2018 Luxembourg, 2019 Luxembourg)

EHA

membre depuis 2018
Organisateur des examens nationaux 20120 et 2021

American Society of Medical Oncology (ASCO)Belgian Immunoscience Academy Steering Committee 
Volontariat / Coopérations

CHU Hue Vietnam 
National Cancer Reference Hospital Timphu, Bhutan
Tu Duc Hospital Ho Chi Minh City, Vietnam

Publications
Editorials

Editor, MediCom oncology congress reports  (depuis 2017)
Membre de l’ Editorial Board, reviewer : Current Problems in Cancer: Case Reports (Elsevier Publ.) 
Reviewer’ Current Problems in Cancer (Elsevier Publ.) 

Publications

Rauh S. (editor). Survivorship Care for Cancer Patients. A Clinician’s Handbook. Springer Nature Switzerland Ag 2021 https://doi.org/10.1007/978-3-030-78648-9   (in print, expected August 2021)

Rauh S. Follow-up and Long-Term Follow-up in Cancer Patients: Who is in Charge, why, when and how… : Introduction: The Evolution from “Surveillance” to “Survivorship Care”. Doi 10.1007/978-3-030-78648-9_4. In :   Rauh S. (editor). Survivorship Care for Cancer Patients. A Clinician’s Handbook. Springer Nature Switzerland Ag 2021 https://doi.org/10.1007/978-3-030-78648-9   (in print, expected August 2021)

Rauh S. Who should be in Charge of Survivorship Care? Doi 10.1007/978-3-030-78648-9_6 in :   Rauh S. (editor). Survivorship Care for Cancer Patients. A Clinician’s Handbook. Springer Nature Switzerland Ag 2021 https://doi.org/10.1007/978-3-030-78648-9   (in print, expected August 2021)

Rauh S. Identifying the Cancer Survivors’ Needs in Daily Practice: Do we have a (Survivorship) Plan? Doi 10.1007/978-3-030-78648-9_7 in :   Rauh S. (editor). Survivorship Care for Cancer Patients. A Clinician’s Handbook. Springer Nature Switzerland Ag 2021 https://doi.org/10.1007/978-3-030-78648-9   (in print, expected August 2021)

Rauh S. Survivorship and Palliative Care: first the one, then the other? Doi 10.1007/978-3-030-78648-9_19 in:   Rauh S. (editor). Survivorship Care for Cancer Patients. A Clinician’s Handbook. Springer Nature Switzerland Ag 2021 https://doi.org/10.1007/978-3-030-78648-9   (in print, expected August 2021)

Backes, C., Moran, V., Berchem, G., Goncharenko, N., Rauh, S., Magalhaes, C., Suhrcke, M., Huiart, L., Couffignal, S., Vogin, G., & Untereiner, M. (2021). Lessons learned from COVID-19 lockdown for cancer care: a nationwide survey of oncologists in Luxembourg. Bulletin de la Societe des Sciences Medicales du Grand-Duche de Luxembourg2020/2, 39-61. https://ssm.lu/wp-content/uploads/2021/01/20202.pdf

Sessa C, Colombo N, Creutzberg CL, Concin N, Wimberger P, Curigliano G, Marinoni K, Douillard JY, Pentheroudakis G, Torri V, Rauh S. Implementing clinical practice guidelines: time to assess it. ESMO Open. 2020 Nov;5(6):e001130. doi: 10.1136/esmoopen-2020-001130. PMID: 33239316; PMCID: PMC7689583.

Rauh S, Mavroeidis L, Ntellas P, Gazouli I, Gkoura S, Papadaki A, Mauri D, Metaxas Y, Douillard JY, Pentheroudakis G. Old drug, new clinical use, no man's land for the indication: an awareness call from European experts. ESMO Open. 2020;5(1):e000615. doi: 10.1136/esmoopen-2019-000615. Epub 2020 Sep 30. PMID: 33551069; PMCID: PMC7046389.

Koncina E, Haan S, Rauh S, Letellier E. 

Prognostic and Predictive Molecular Biomarkers for Colorectal Cancer: Updates and Challenges. Cancers (Basel). 2020 Jan 30;12(2):319. doi: 10.3390/cancers12020319. PMID: 32019056; PMCID: PMC7072488.

Derksen JWG, Warren GW, Jordan K, Rauh S, Vera García R, O'Mahony D, Ahmed S, Vuylsteke P, Radulovic S, Tsoukalas N, Wysocki PJ, Borner M, Cesas A, Elme A, Minn H, Ullenhag GJ, Roodhart JML, Koopman M, May AM. European practice patterns and barriers to smoking cessation after a cancer diagnosis in the setting of curative versus palliative cancer treatment. Eur J Cancer. 2020 Oct;138:99-108. doi: 10.1016/j.ejca.2020.07.020. Epub 2020 Aug 29. PMID: 32871527.

Rauh S, Antonuzzo A, Bossi P, Eckert R, Fallon M, Fröbe A, Gonella S, Giusti R, Lakatos G, Santini D, Villarini A. Nutrition in patients with cancer: a new area for medical oncologists? A practising oncologist's interdisciplinary position paper. ESMO Open. 2018 May 5;3(4):e000345. doi: 10.1136/esmoopen-2018-000345. PMID: 29765772; PMCID: PMC5950635.

Rauh S, Arnold D, Braga S, Curca R, Eckert R, Fröbe A, Karamouzis M, Lakatos G, Molitor JL. Challenge of implementing clinical practice guidelines. Getting ESMO's guidelines even closer to the bedside: introducing the ESMO Practising Oncologists' checklists and knowledge and practice questions. ESMO Open. 2018 Jul 25;3(5):e000385. doi: 10.1136/esmoopen-2018-000385. PMID: 30094071; PMCID: PMC6069906.

S. Rauh, L. Hoechstenbach, C. Schmitz, A. Hagemann, I. Denine. Outpatient monitoring with an eTool: self managed or with pro active intervention? Ann Oncol 2017 Vol 28, Suppl 5, V566 DOI: https://doi.org/10.1093/annonc/mdx388.070

Tabernero J, Vyas M, Giuliani R, Arnold D, Cardoso F, Casali PG, Cervantes A, Eggermont AMM, Eniu A, Jassem J, Pentheroudakis G, Peters S, Rauh S, Zielinski CC, Stahel RA, Voest E, Douillard JY, McGregor K, Ciardiello F. Biosimilars: a position paper of the European Society for Medical Oncology, with particular reference to oncology prescribers. ESMO Open. 2017 Jan 16;1(6):e000142. doi: 10.1136/esmoopen-2016-000142. PMID: 28848668; PMCID: PMC5419210.

Morgan G, Lambertini M, Kourie HR, Amaral T, Argiles G, Banerjee S, Cardone C, Corral J, De Mattos-Arruda L, Öztürk A, Petrova M, Poulsen L, Strijbos M, Tyulyandina A, Vidra R, Califano R, de Azambuja E, Garrido Lopez P, Guarneri V, Reck M, Moiseyenko V, Martinelli E, Douillard JY, Stahel R, Voest E, Arnold D, Cardoso F, Casali P, Cervantes A, Eggermont AMM, Eniu A, Jassem J, Pentheroudakis G, Peters S, McGregor K, Rauh S, Zielinski CC, Ciardiello F, Tabernero J, Preusser M.: Career opportunities and benefits for young oncologists in the European Society for Medical Oncology (ESMO). ESMO Open. 2016 Dec 7;1(6):e000107. doi: 10.1136/esmoopen-2016-000107. PMID: 28255451; PMCID: PMC5174792.

Sharaf M, Rauh S. A Retrospective Study looking at Admissions Characteristics of Patients admitted to an Oncology Ward in Luxembourg. Bull Soc Sci Med Grand Duche Luxemb. 2016;1:69-76. PMID: 29468862.

Fröbe A, Murgić J, Rauh S. Single institution long-term efficacy and safety analysis of abiraterone acetate (AA) in the treatment of patients with metastatic castration-resistant prostate cancer (mCRPC) in a named patient programme (NPP). ESMO Open. 2016 May 17;1(3):e000049. doi: 10.1136/esmoopen-2016-000049. PMID: 27843608; PMCID: PMC5070301.

Moran T, Wei J, Cobo M, Qian X et al , Domine M, Zou Z, Bover I, Wang L, Provencio M, Yu L, Chaib I, You C, Massuti B, Song Y, Vergnenegre A, Lu H, Lopez-Vivanco G, Hu W, Robinet G, Yan J, Insa A, Xu X, Majem M, Chen X, de Las Peñas R, Karachaliou N, Sala MA, Wu Q, Isla D, Zhou Y, Baize N, Zhang F, Garde J, Germonpre P, Rauh S, et al. Two biomarker-directed randomized trials in European and Chinese patients with non-small-cell lung cancer: the BRCA1-RAP80 Expression Customization (BREC) studies. Ann Oncol. 2014 Nov;25(11):2147-2155. doi: 10.1093/annonc/mdu389. Epub 2014 Aug 27. PMID: 25164908.

Eckert R, Curca R, D'Addario G, Lanzetta G, Martorell PM, Mauri D, Rauh S, Schmitz S, Tamas K, Karamouzis MV. What do European community oncologists expect from the European Society for Medical Oncology? Results from a survey among community oncologists in Germany, Greece, Hungary, Italy, Luxembourg, Romania, and Spain . Ann Oncol. 2013 May;24(5):1419-20. doi: 10.1093/annonc/mdt101. Epub 2013 Mar 15.

Cohen AT, Spiro TE, Büller HR, Haskell L, Hu D, Hull R, Mebazaa A, Merli G, Schellong S, Spyropoulos AC, Tapson V; MAGELLAN Investigators. Rivaroxaban for thromboprophylaxis in acutely ill medical patients. N Engl J Med. 2013 Feb 7;368(6):513-23. doi: 10.1056/NEJMoa1111096. PMID: 23388003.

Walz C, Metzgeroth G, Haferlach C, Schmitt-Graeff A, Fabarius A, Hagen V, Prümmer O, Rauh S, Hehlmann R, Hochhaus A, Cross NC, Reiter A. Characterization of three new imatinib-responsive fusion genes in chronic myeloproliferative disorders generated by disruption of the platelet-derived growth factor receptor beta gene. Haematologica. 2007 Feb;92(2):163-9.

Rauh S, Simon M, Harf C, Welter R, Duhoux P.Cholesterol embolism: an often unknown disease; a report of two cases. Bull Soc Sci Med Grand Duche Luxemb. 1999;(2):37-43. 

Rauh S, Duhem C, Ries F, Dicato M.Complications and hospitalisation--duration after chemoembolisation for liver metastases .Bull Soc Sci Med Grand Duche Luxemb. 1999;(2):29-36.

Rauh S, Dicato M, Duhem C, Ries F. [New diagnostic approaches to deep venous thrombosis] .Bull Soc Sci Med Grand Duche Luxemb. 1997;134(1):21-4. 

Rauh S, Duhem C, Mahassen P, Ries F, Dicato M.[Immunophenotyping in the diagnosis of non-Hodgkin lymphomas: a literature review]. Bull Soc Sci Med Grand Duche Luxemb. 1996;133(2):27-33.   

Ines Vaz-Luis, Marianna Masiero, Guido Cavaletti, Andrés Cervantes, Rowan T Chlebowski, Giuseppe Curigliano, Enriqueta Felip, Arlindo R. Ferreira, Patricia A Ganz, Josephine Hegarty, Justin Jeon, Christoffer Johansen, Florence Joly, Karin Jordan, Bogda Koczwara, Pernilla Lagergren, Matteo Lambertini, Daniel Lenihan, Helena Linardou, Charles Loprinzi, Ann H Partridge, Stefan Rauh, Karen Steindorf, Winette van der Graaf, Lonneke van de Poll-Franse, George Pentheroudakis, Solange Peters, Gabriella Pravettoni: ESMO Expert Consensus Statements on Cancer Survivorship: promoting high-quality survivorship care and research in Europe.

 

Cabinet médical

Résidence du Parc, 15, rue Michel Rodange,
L-4660 Differdange

Téléphone

+352 26 58 75 1

Fax

+352 26 58 75 75